Globus Price To Sales Ratio from 2010 to 2024

GMED Stock  USD 50.75  0.45  0.88%   
Globus Medical's Price To Sales Ratio is increasing over the years with slightly volatile fluctuation. Overall, Price To Sales Ratio is expected to go to 4.16 this year. Price To Sales Ratio is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
3.84220494
Current Value
4.16
Quarterly Volatility
1.75931148
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus main balance sheet or income statement drivers, such as Depreciation And Amortization of 152 M, Interest Expense of 21.1 M or Total Revenue of 1.6 B, as well as many exotic indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 1.43. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
  
This module can also supplement Globus Medical's financial leverage analysis and stock options assessment as well as various Globus Medical Technical models . Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Latest Globus Medical's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Globus Medical over the last few years. Price to Sales Ratio is figured by comparing Globus Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Globus Medical sales, a figure that is much harder to manipulate than other Globus Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Globus Medical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Globus Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.46 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Globus Price To Sales Ratio Regression Statistics

Arithmetic Mean5.25
Geometric Mean4.97
Coefficient Of Variation33.49
Mean Deviation1.48
Median4.72
Standard Deviation1.76
Sample Variance3.10
Range5.7131
R-Value0.51
Mean Square Error2.46
R-Squared0.26
Significance0.05
Slope0.20
Total Sum of Squares43.33

Globus Price To Sales Ratio History

2024 4.16
2023 3.84
2022 7.3
2021 7.59
2020 8.15
2019 7.43
2018 5.94

About Globus Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Globus Medical income statement, its balance sheet, and the statement of cash flows. Globus Medical investors use historical funamental indicators, such as Globus Medical's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may use each financial statement separately, they are all related. The changes in Globus Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Globus Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Globus Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 3.84  4.16 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.